LONG COVID SYNDROME
Clinical trials for LONG COVID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LONG COVID SYNDROME trials appear
Sign up with your email to follow new studies for LONG COVID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could anktiva help long COVID sufferers? new trial launches
Disease control Recruiting nowThis study tests a drug called Anktiva (NAI) in 40 adults with Long COVID—symptoms that stick around after a COVID infection clears. The main goal is to see if the drug is safe, and researchers will also check if it helps reduce symptoms. Participants must be between 18 and 70 an…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
Could a blood filter cure long COVID? new trial aims to find out
Disease control Recruiting nowSome people with long COVID have symptoms like extreme fatigue because their immune system attacks their own body. This study tests a treatment called immunoadsorption, which filters the blood to remove harmful antibodies. About 70 adults with long COVID and these antibodies will…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Taurine trial aims to ease long COVID symptoms
Symptom relief Recruiting nowThis study tests whether taking taurine, a common amino acid supplement, for 12 weeks can improve blood vessel health and reduce dizziness in people with Long COVID. Researchers will measure blood flow and heart function in 30 adults before and after the supplement period. The go…
Matched conditions: LONG COVID SYNDROME
Sponsor: York University • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
Could a cancer drug ease long COVID? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether the drug plitidepsin can safely improve overall health in people with long COVID. About 90 adults with moderate-to-severe symptoms will receive either the drug or a placebo through an IV over four treatment cycles. Researchers will measure changes in heal…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Heart MRI breakthrough could spot hidden disease in thousands
Knowledge-focused Recruiting nowThis study aims to improve how doctors predict heart problems by using a special MRI technique called T1 mapping. Researchers will scan 6,000 adults, including people with Long COVID, to establish normal ranges for heart tissue measurements. The goal is to better identify those a…
Matched conditions: LONG COVID SYNDROME
Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC